<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38225964</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2542-4823</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease reports</Title><ISOAbbreviation>J Alzheimers Dis Rep</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19 Symptoms in People with Dementia or Mild Cognitive Impairment.</ArticleTitle><Pagination><StartPage>1371</StartPage><EndPage>1375</EndPage><MedlinePgn>1371-1375</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/ADR-230119</ELocationID><Abstract><AbstractText>What is the impact of long COVID-19 on people with mild cognitive impairment (MCI) or dementia? Self-reported questionnaire was used for the report of long COVID-19 symptoms. People with MCI or dementia or their caregivers regarding patients' health were recruited COVID-19 throughout from the Athens Alzheimer's Association. We included 72 participants. Thirty had the diagnosis of MCI and 39 had dementia. Most symptoms lasted for 3-4 weeks. The majority of patients reported having all the symptoms, with fatigue being the major disturbance. The diagnosis and the management of long COVID-19 symptoms requires a more holistic and comprehensive approach.</AbstractText><CopyrightInformation>&#xa9; 2023 &#x2013; The authors. Published by IOS Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsapanou</LastName><ForeName>Angeliki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Athens Alzheimer's Association, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cognitive Neuroscience Division, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoi</LastName><ForeName>Panagiota</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Athens Alzheimer's Association, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalligerou</LastName><ForeName>Faidra</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Athens Alzheimer's Association, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blekou</LastName><ForeName>Patra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Athens Alzheimer's Association, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakka</LastName><ForeName>Paraskevi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Athens Alzheimer's Association, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis Rep</MedlineTA><NlmUniqueID>101705500</NlmUniqueID><ISSNLinking>2542-4823</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mild cognitive impairment</Keyword></KeywordList><CoiStatement>The authors have no conflict of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38225964</ArticleId><ArticleId IdType="pmc">PMC10789283</ArticleId><ArticleId IdType="doi">10.3233/ADR-230119</ArticleId><ArticleId IdType="pii">ADR230119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu Y-H, Chen Y, Wang Q-H, Wang L-R, Jiang L, Yang Y, Chen X, Li Y, Cen Y, Xu C, Zhu J, Li W, Wang Y-R, Zhang L-L, Liu J, Xu Z-Q, Wang Y-J One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study. JAMA Neurol (2022) 79, 509&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Soysal P, Smith L, Trott M, Alexopoulos P, Barbagallo M, Tan SG, Koyanagi A, Shenkin S, Veronese N; European Society of Geriatric Medicine Special Interest Group in Dementia and Systematic Reviews and Meta-Analyses The effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis. Psychogeriatrics (2022) 22, 402&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115368</ArticleId><ArticleId IdType="pubmed">35128762</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, Harrison PJ Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry (2022) 9, 815&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z Long-term neurologic outcomes of COVID-19. Nat Med (2022) 28, 2406&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S, Das S, Ghosh R, Dubey MJ, Chakraborty AP, Roy D, Das G, Dutta A, Santra A, Sengupta S, Benito-Le&#xf3;n J The effects of SARS-CoV-2 infection on the cognitive functioning of patients with pre-existing dementia. J Alzheimers Dis Rep (2023) 7, 119&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9986710</ArticleId><ArticleId IdType="pubmed">36891252</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsapanou A, Papatriantafyllou JD, Yiannopoulou K, Sali D, Kalligerou F, Ntanasi E, Zoi P, Margioti E, Kamtsadeli V, Hatzopoulou M, Koustimpi M, Zagka A, Papageorgiou SG, Sakka P The impact of COVID-19 pandemic on people with mild cognitive impairment/dementia and on their caregivers. Int J Geriatr Psychiatry (2021) 36, 583&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">33166418</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsapanou A, Zoi P, Kalligerou F, Blekou P, Sakka P The effect of prolonged lockdown due to COVID-19 on Greek demented patients of different stages and on their caregivers. J Alzheimers Dis (2021) 83, 907&#x2013;913.</Citation><ArticleIdList><ArticleId IdType="pubmed">34308909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Guo Y, Lipsitch M, Daugherty SE Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ (2022) 376, e068414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature (2022) 604, 697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-Junior JWL, de Souza ACC, Borges JWP, Oliveira DN, Siqueira-Neto JI, Sobreira-Neto MA, Braga-Neto P COVID-19 associated cognitive impairment: A systematic review. Cortex (2022) 152, 77&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-Junior JWL, Oliveira DN, da Silva JBS, Feitosa WLQ, Sousa AVM, Cunha LCV, Gaspar SB, Gomes CMP, de Oliveira LLB, Moreira-Nunes CA, Montenegro RC, Sobreira-Neto MA, Braga-Neto P Long-covid cognitive impairment: Cognitive assessment and apolipoprotein E (APOE) genotyping correlation in a Brazilian cohort. Front Psychiatry (2022) 13, 947583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9423011</ArticleId><ArticleId IdType="pubmed">36046159</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>